Shyam Kambeyanda
Known title: DirectorCIK: 0001673243
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
ESAB Schedules Q3 2026 Earnings Call Amid Mixed Stock Performance. ESAB has announced the schedule for its third-quarter 2026 earnings release and conference call. This announcement follows a period of mixed price action, with recent reports noting both sharp declines and significant gains in the stock. The company is preparing to share updated financial results as investors monitor its performance against a 52-week range of $64.83 to $137.42.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Enovis joins AAOS Registry Program as industry sponsor. Enovis has become the first multi-registry industry sponsor of the AAOS Registry Program. This move highlights the company's engagement with major orthopedic data initiatives. The stock is currently trading near its 52-week low, with an average analyst target of $38.33.
Transaction History
| VLTO | ▲ Buy | Grant | 1,099 | $0 | 7/15/2026 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 10,796 | — | 5/12/2026 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 5,053 | $476K | 5/12/2026 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 6,124 | — | 3/9/2026 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 2,867 | $307K | 3/9/2026 | View on chart |
| ESAB | ▲ Buy | Grant | 23,146 | — | 3/9/2026 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 11,377 | $1.2M | 3/9/2026 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 3,808 | — | 3/2/2026 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 1,872 | $228K | 3/2/2026 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 59,404 | $2.0M | 2/23/2026 | View on chart |
| ESAB | ▼ Sell | Open Market | 32,286 | $4.0M | 2/23/2026 | View on chart |
| ESAB | ▼ Sell | Open Market | 12,705 | $1.6M | 2/23/2026 | View on chart |
| ESAB | ▼ Sell | Open Market | 10,813 | $1.4M | 2/23/2026 | View on chart |
| ESAB | ▼ Sell | Open Market | 1,300 | $164K | 2/23/2026 | View on chart |
| ESAB | ▼ Sell | Open Market | 600 | $77K | 2/23/2026 | View on chart |
| ESAB | ▼ Sell | Open Market | 1,700 | $219K | 2/23/2026 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 4,466 | — | 2/23/2026 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 2,091 | $256K | 2/23/2026 | View on chart |
| VLTO | ▲ Buy | Grant | 818 | $0 | 7/15/2025 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 11,809 | — | 5/12/2025 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 5,705 | $734K | 5/12/2025 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 10,796 | — | 5/12/2025 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 5,215 | $671K | 5/12/2025 | View on chart |
| ESAB | ▲ Buy | Grant | 38,862 | — | 5/12/2025 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 18,771 | $2.4M | 5/12/2025 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 2,958 | $362K | 3/10/2025 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 6,123 | — | 3/10/2025 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 4,466 | $0 | 2/24/2025 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 2,158 | $262K | 2/24/2025 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 1,166 | $154K | 2/18/2025 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 14,474 | $0 | 2/18/2025 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 2,413 | — | 2/18/2025 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 7,008 | $923K | 2/18/2025 | View on chart |
| ESAB | ▼ Sell | Open Market | 3,650 | $458K | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 1,200 | $146K | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 10,361 | $1.3M | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 3,159 | $391K | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 3,271 | $408K | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 2,500 | $301K | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 428 | $54K | 10/29/2024 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 46,562 | $1.9M | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 10,202 | $1.2M | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 4,000 | $485K | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 7,500 | $920K | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 10,849 | $1.3M | 10/29/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 2,000 | $245K | 10/29/2024 | View on chart |
| VLTO | ▲ Buy | Grant | 842 | $0 | 7/15/2024 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 5,704 | $629K | 5/12/2024 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 11,808 | — | 5/12/2024 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 6,123 | — | 3/8/2024 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 2,958 | $298K | 3/8/2024 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 4,660 | — | 3/5/2024 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 2,251 | $223K | 3/5/2024 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 7,274 | $682K | 2/22/2024 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 2,510 | — | 2/22/2024 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 1,213 | $114K | 2/22/2024 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 15,060 | — | 2/22/2024 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 2,412 | — | 2/17/2024 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 1,187 | $111K | 2/17/2024 | View on chart |
| ESAB | ▼ Sell | Open Market | 6,702 | $543K | 12/8/2023 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 27,098 | $2.2M | 12/7/2023 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 33,800 | $1.7M | 12/7/2023 | View on chart |
| VLTO | ▲ Buy | Grant | 711 | $0 | 11/15/2023 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 11,808 | — | 5/12/2023 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 5,704 | $339K | 5/12/2023 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 4,659 | — | 3/6/2023 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 2,251 | $137K | 3/6/2023 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 2,722 | — | 2/24/2023 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 11,437 | — | 2/24/2023 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 5,525 | $316K | 2/24/2023 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 1,315 | $75K | 2/24/2023 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 2,509 | — | 2/22/2023 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 1,212 | $69K | 2/22/2023 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 2,412 | — | 2/17/2023 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 1,199 | $70K | 2/17/2023 | View on chart |
| ESAB | ▼ Sell | Tax Withholding | 1,899 | $91K | 12/13/2022 | View on chart |
| ESAB | ▲ Buy | Option Exercise | 3,930 | — | 12/13/2022 | View on chart |
| ESAB | ▲ Buy | Grant | 24,102 | $0 | 4/5/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 2,788 | $108K | 3/7/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 21,190 | $875K | 2/28/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 1,629 | $69K | 2/25/2022 | View on chart |
| ENOV | ▲ Buy | Grant | 44,145 | $0 | 2/25/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 1,533 | $64K | 2/23/2022 | View on chart |
| ENOV | ▲ Buy | Grant | 9,019 | $0 | 2/17/2022 | View on chart |
| ENOV | ▼ Sell | Open Market | 2,366 | $105K | 12/14/2021 | View on chart |
| ENOV | ▼ Sell | Open Market | 24,644 | $1.2M | 10/15/2021 | View on chart |
| ENOV | ▲ Buy | Option Exercise | 24,644 | $615K | 10/15/2021 | View on chart |
| ENOV | ▼ Sell | Open Market | 15,218 | $771K | 10/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Veralto Sets Date for Q3 2026 Earnings Call
Veralto has announced the schedule for its third-quarter 2026 earnings call, providing investors with a specific date to review upcoming financial results. This announcement is a standard corporate disclosure that helps the market prepare for the next major update on the company's performance. The stock is currently trading near its 52-week high, reflecting strong recent momentum ahead of this scheduled event.
Veralto Sets Date for Q3 2026 Earnings Call. Veralto has announced the schedule for its third-quarter 2026 earnings call, providing investors with a specific date to review upcoming financial results. This announcement is a standard corporate disclosure that helps the market prepare for the next major update on the company's performance. The stock is currently trading near its 52-week high, reflecting strong recent momentum ahead of this scheduled event.